未复杂TSC1部署了新的mTORC1独立途径,以加剧TSC中的肝脏糖原储存
Xiaoqiao Yue1,2, Yanping Zhang1,2, Na Zhao3
1Institutes of Biomedical Sciences, Shanxi University, Taiyuan, China.
Cell death & disease
|November 14, 2025
概括
结核性硬化综合体 (TSC) 涉及通过mTORC1-独立途径储存多余的糖原. 将METTL3与mTORC1一起定位显示了治疗目前对当前疗法的反应不佳的TSC患者的潜力.
科学领域:
- 遗传学和分子生物学
- 细胞的新陈代谢
- 疾病机制 疾病机制
背景情况:
- 结核性硬化综合体 (TSC) 是一种与TSC1/TSC2突变和mTORC1过活化相关的自体主导性疾病.
- 有助于TSC病变的mTORC1-独立途径尚不清楚.
- 过多的糖原积累是TSC模型的一个特征.
研究的目的:
- 阐明新的mTORC1-独立机制驱动TSC中的糖原储存.
- 研究TSC1/TSC2缺乏在糖原代谢中的作用.
- 确定TSC的潜在治疗点,特别是对对mTORC1抑制剂反应有限的患者.
主要方法:
- 使用 Tsc1/Tsc2 缺陷细胞系和小鼠模型.
- 分析了与糖原合成相关的蛋白质相互作用和基因表达.
- 研究了KDM5A,METTL3,IGF2BP2和GYS2在糖原积累中的作用.
- 在体内评估联合mTORC1和METTL3抑制的治疗疗效.
主要成果:
- 在TSC模型中显示出显著的多余糖原储存,在TSC2缺陷中更为明显.
- 发现了一种新的mTORC1独立途径:TSC1-KDM5A-METTL3-IGF2BP2-GYS2,调节糖原合成.
- 证明TSC1缺乏下调KDM5A,导致METTL3上调和随后的GYS2稳定和糖原储存.
- 证实了mTORC1和METTL3的联合抑制改善了肝病变,并恢复了TSC2缺陷小鼠中的葡萄糖原平衡.
结论:
- 确定了一种新型的mTORC1-独立途径,该途径负责TSC中的多余糖原储存.
- mTORC1-依赖和独立路径之间的协同作用解释了TSC2突变中更严重的表型.
- 针对mTORC1和METTL3的组合疗法为TSC患者提供了一个有前途的治疗策略,特别是那些TSC2突变和对mTORC1抑制剂有限反应的TSC2患者.
更多相关视频
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.4K
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
611
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
TGF - β Signaling Pathway
10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K
MAPK Signaling Cascades
7.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
cAMP-dependent Protein Kinase Pathways
8.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.3K
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
